Fox Chase Cancer Center News

SAN DIEGO, CA (April 6, 2014)—Tumor cells are picky about where they live. In the wrong environment, they fail to reach their potential. But put those same cells on the right bit of real estate, and they grow like mad.  Researchers at Fox Chase Cancer Center found renal cancer cells planted in a supportive environment proliferate with the help of an enzyme usually only seen in the brain.

SAN DIEGO, CA (April 6, 2014)—Researchers from Fox Chase Cancer Center have shown that NEDD9, a scaffolding protein responsible for regulating signaling pathways in the cell, promotes the growth and spread of epithelial ovarian cancer.

(Philadelphia, March 26, 2014)- Temple Health is once again well represented in the latest Best Doctors in America® List. Eighty-three (83) Temple physicians have been named to the "Best Doctors" list for 2014, which includes physicians that practice at Temple University Hospital, Temple University Hospital-Episcopal Campus, Jeanes Hospital, and Fox Chase Cancer Center. Only five percent of doctors in America earn a spot on the prestigious list, which is assembled by Best Doctors, Inc.® and audited and certified by Gallup®.

PHILADELPHIA, PA (March 25, 2014)—Michael H. Levy, MD, PhD, Vice Chair of Medical Oncology and Director of the Pain and Palliative Care Program at Fox Chase Cancer Center, will be honored with the American Society of Clinical Oncology’s (ASCO) inaugural Excellence in Teaching Award at the organization’s 2014 Annual Meeting in Chicago in May. Dr. Levy is a leading palliative care expert who, in addition to his role at Fox Chase, is past president of the American Academy of Hospice and Palliative Medicine.

PHILADELPHIA, PA (March 24, 2014)—Fox Chase Cancer Center will be hosting a Cancer Conversations LIVE event featuring author George Johnson—former New York Times editor and writer—on Thursday, April 3 at 7:00 p.m. in the Fox Chase Auditorium (Center Building, 333 Cottman Avenue, Philadelphia).

PHILADELPHIA, PA (March 6, 2014)—Stephen C. Rubin, MD, has joined the Department of Surgical Oncology at Fox Chase Cancer Center as Chief of Gynecologic Oncology, where he will specialize in the treatment of patients with gynecologic cancers—including ovarian, uterine, cervical, and endometrial. Dr. Rubin has also been named Co-Clinical Leader of the Gynecological Service Line and Professor in the clinical investigator track of the Department of Surgical Oncology. In addition, he will hold the Paul Grotzinger and Wilbur Raab Chair in Surgical Oncology.

PHILADELPHIA (February 21, 2014) – Accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT) signifies excellence in all quality aspects of patient care and collection practices related to cellular therapy treatments.

PHILADELPHIA, PA (February 20, 2014)—In the cells of humans and other organisms, only a subset of genes are active at any given time, depending largely on the stage of life and the particular duties of the cell. Cells use different molecular mechanisms to orchestrate the activation and deactivation of genes as needed. One central mechanism is an intricate DNA packaging system that either shields genes from activation or exposes them for use.